Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2011 on Tuesday, March 6, 2012, after the financial markets close. Following the release of the financial results, Allos management will provide a corporate update via conference c

Feed Date: 
February 21, 2012